Rodgers GM 3rd, Becker PS, Blinder M, Cella D, Chanan-Khan A, Cleeland C, et al. Cancer- and chemotherapy- induced anemia. J Natl Compr Cancer Netw. 2012;10:628–53.
Kuter DJ. Managing thrombocytopenia associated with cancer chemotherapy. Oncology (Willis-ton Park). 2015;29:282–94.
de Naurois J, Novitzky-Basso I, Gill JM, Marti F, Cullen MH, Roila F. Management of febrile neutropenia: ESMO Clinical Practice Guidelines. Ann Oncol. 2010;21(supplement 5):v252–6.
National Comprehensive Care Network I. NCCN Clinical Practice Guidlines for Oncology (NCCN Guidlines); Antiemesis. 2015.
Andreyev J, Ross P, Donnellan C, Lennan E, Leonard P, Waters C, et al. Guidance on the management of diarrhoea during cancer chemotherapy. Lancet Oncol. 2014;15:e447–60.
Brewer JR, Morrison G, Dolan ME, Fleming GF. Chemotherpay-induced peripheral neuropathy. Current status and progress. Gynecol Oncol. 2015;140(1):176–83.
Curigliano G, Cardinale D, Super T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, et al. On behalf of the ESMO Guidelines Working Group, Cardiovascular toxicity induced by chemo-therapy, targeted agents and radiotherapy: clinical practice guidelines. Ann Oncol. 2012;23(Supplement 7):vii155–66.
Ripamonti C. Management of bowel obstruction in advanced cancer. Curr Opin Oncol. 1994;6:351–7.
Ripamonti C, Bruera E. Palliative management of malignant bowel obstruction. Int J Gynecol Cancer. 2002;12:135–43.
Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Human Pathol. 1988;19:57–83.
Kolomainen DF, Riley J, Wood J, Barton DPJ. Surgical management of bowel obstruction in gynaecological cancer. Obstet Gynaecol. 2017;19:63–70.
Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;2000(1):CD001219.
Ten Broek RPG, Krielen P, Di Saverio S, et al. Bologna guidelines for diagnosis and management of adhesive small bowel obstruction (ASBO): 2017 update of the evidence-based guidelines from the world society of emergency surgery ASBO working group. World J Emerg Surg. 2018;19(13):24.
Catena F, Ansaloni L, Gazzotti F, et al. Small bowel tumours in emergency surgery: specificity of clinical presentation. ANZ J Surg. 2005;75(11):997–9.
Vallicelli C, Coccolini F, Catena F, et al. Small bowel emergency surgery: literature’s review. World J Emerg Surg. 2011;6(1):1.
Yeo HL, Lee SW. Colorectal emergencies: review and controversies in the management of large bowel obstruction. J Gastrointest Surg. 2013;17(11):2007–12.
Pisano M, Zorcolo L, Merli C, et al. 2017 WSES guidelines on colon and rectal cancer emergencies: obstruction and perforation. World J Emerg Surg. 2018;13(13):36.
Catena F, Pasqualini E, Tonini V, Avanzolini A, Campione O. Emergency surgery for patients with colorectal cancer over 90 years of age. Hepatogastroenterology. 2002;49(48):1538–9.
Takahashi H, Okabayashi K, Tsuruta M, Hasegawa H, Yahagi M, Kitagawa Y. Self-expanding metallic stents versus surgical intervention as palliative therapy for obstructive colorectal cancer: a meta-analysis. World J Surg. 2015;39(8):2037–44.
Rath K, Loseth D, Muscarella P, Phillips G, Fowler J, Mall D, et al. Outcomes following percutaneous upper gastrointestinal decompressive tube placement for malignant bowel obstruction in ovarian cancer. Gynecol Oncol. 2013;129:103–6.
Tamsma J. The pathogenesis of malignant ascites. Cancer Treat Res. 2007;134:109–18.
Meyer L, Suidan R, Sun C, Westin S, Coleman RL, Mills GB. The management of malignant ascites and impact on quality of life outcomes in women with ovarian cancer. Expert Rev Qual Life Cancer Care. 2016;1(3):231–8.
Hodge C, Badgwell BD. Palliation of malignant ascites. J Surg Oncol. 2019;120(1):67–73.
Macdonald R, Kirwan J, Roberts S, Gray D, Allsopp L, Green J. Ovarian cancer and ascites: a questionnaire on current management in the United Kingdom. J Palliat Med. 2006;9:1264–70.
O’Neill MJ, Weissleder R, Gervais DA, Hahn PF, Mueller PR. Tunneled peritoneal catheter placement under sonographic and fluoroscopic guidance in the palliative treatment of malignant ascites. AJR Am J Roentgenol. 2001;177:615–8.
Pockros PJ, Esrason KT, Nguyen C, Duque J, Woods S. Mobilization of malignant ascites with diuretics is dependent on ascitic fluid characteristics. Gastroenterology. 1992;103:1302–6.
Hirte HW, Miller D, Tonkin K, Findlay B, Capstick V, Murphy J, et al. A randomized trial of paracentesis plus intraperitoneal tumor necrosis factor-α versus paracentesis alone in patients with symptomatic ascites from recurrent ovarian carcinoma. Gynecol Oncol. 1997;64:80–7.
Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13:273–82.
Seimetz D, Lindhofer H, Bokemeyer C. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM × anti-CD3) as a targeted cancer immunotherapy. Cancer Treat Rev. 2010;36:458–67.
Skok K, Hladnik G, Grm A, Crnjac A. Malignant pleural effusion and its current management: a review. Medicina (Kaunas). 2019;55(8):490.
Porcel JM, Diaz JP, Chi DS. Clinical implications of pleural effusions in ovarian cancer. Respirology. 2012;17:1060–7.
Ataseven B, Chiva LM, Harter P, Gonzalez-Martin A, du Bois A. FIGO stage IV epithelial ovarian, fallopian tube and peritoneal cancer revisited. Gynecol Oncol. 2016;142:597–607.
Desai NR, Lee HJ. Diagnosis and management of malignant pleural effusions: state of the art in 2017. J Thorac Dis. 2017;9:S1111–22.
Li P, Graver A, Hosseini S, Mulpuru S, Cake L, Kachuik L, Zhang T, Amjadi K. Clinical predictors of successful and earlier pleurodesis with a tunnelled pleural catheter in malignant pleural effusion: a cohort study. CMAJ Open. 2018;6:E235–40.
Sterman DH, DeCamp MM, Feller-Kopman DJ, Maskell NA, Wahidi MM, Lee YCG, Gould MK, Rahman NM, Lewis SZ, Henry T, et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med. 2018;198:839–49.
Bibby AC, Dorn P, Psallidas I, Porcel JM, Janssen J, Froudarakis M, Subotic D, Astoul P, Licht P, Schmid R, et al. ERS/EACTS statement on the management of malignant pleural effusions. Eur J Cardiothorac Surg. 2019;55:116–32.
Cohen A, Lim CS, Davies AH. Venous thromboembolism in gynecological malignancy. Int J Gynecol Cancer. 2017;27:1970–8.
Satoh T, Matsumoto K, Tanaka YO, et al. Incidence of venous thromboembolism before treatment in cervical cancer and the impact of management on venous thromboembolism after commencement of treatment. Thromb Res. 2013;131:e127Ye132.
Piccioli A, Falanga A, Baccaglini U, et al. Cancer and venous thromboembolism. Semin Thromb Hemost. 2006;32:694Y699.
Barbera L, Thomas G. Venous thromboembolism in cervical cancer. Lancet Oncol. 2008;9:54Y60.
Khorana AA, Dalal M, Lin J, et al. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119:648Y655.
Barber EL, Clarke-Pearson DL. Prevention of venous thromboembolism in gynecologic oncology surgery. Gynecol Oncol. 2017;144:420–7.
Selby LV, Sovel M, Sjoberg DD, McSweeney M, Douglas D, Jones DR, et al. Pre-operative chemoprophylaxis is safe major oncology operations and effective at preventing venous thromboembolism. J Am Coll Surg. 2016;222:129–37.
Raskob GE, Hirsh J. Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest. 2003;124:379–85.
van den Beuken-van Everdingen MH, Hochstenbach LM, Joosten EA, Tjan-Heijnen VC, Janssen DJ. Update on prevalence of pain in patients with cancer: systematic review and meta-analysis. J Pain Symptom Manage. 2016;51(6):1070–1090.e9.
Syrjala KL, Jensen MP, Mendoza ME, Yi JC, Fisher HM, Keefe FJ. Psychological and behavioral approaches to cancer pain management. J Clin Oncol. 2014;32(16):1703–11. https://doi.org/10.1200/JCO.2013.54.4825.
Manolitas TP, Abdessalam S, Fowler JM. Chylous ascites following treatment for gynecologic malignancies. Gynecol Oncol. 2002;86:370–3.
Al-Busafi SA, Ghali P, Deschênes M, Wong P. Chylous ascites: evaluation and management. International Scholarly Research Notices. 2014; Article ID 240473. https://doi.org/10.1155/2014/240473
Baiocchi G, Faloppa CC, Araujo RLC, et al. Chylous ascites in gynecologic malignancies: cases report and literature review. Arch Gynecol Obstet. 2010;281:677–81.